166 related articles for article (PubMed ID: 24268385)
1. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
Bryant D; Hibbitts S; Almonte M; Tristram A; Fiander A; Powell N
J Clin Virol; 2015 May; 66():66-71. PubMed ID: 25866341
[TBL] [Abstract][Full Text] [Related]
3. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
4. Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Rong S; Okunieff P; Zhang L; Li X
J Virol Methods; 2015 Nov; 224():35-41. PubMed ID: 26297960
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
6. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
[TBL] [Abstract][Full Text] [Related]
7. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.
Lorincz AT; Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Castanon A; Fiander A; Powell N; Tristram A; Cuzick J; Sasieni P
Int J Cancer; 2013 Aug; 133(3):637-44. PubMed ID: 23335178
[TBL] [Abstract][Full Text] [Related]
8. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
9. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing.
Gillio-Tos A; Fiano V; Grasso C; Trevisan M; Gori S; Mongia A; De Marco L; Ronco G;
PLoS One; 2018; 13(3):e0194619. PubMed ID: 29579066
[TBL] [Abstract][Full Text] [Related]
10. Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia.
Bryant D; Onions T; Raybould R; Jones S; Tristram A; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Nov; 61(3):393-9. PubMed ID: 25218242
[TBL] [Abstract][Full Text] [Related]
11. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia.
Oka N; Kajita M; Nishimura R; Ohbayashi C; Sudo T
Int J Gynecol Cancer; 2013 Feb; 23(2):235-43. PubMed ID: 23314283
[TBL] [Abstract][Full Text] [Related]
12. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
[TBL] [Abstract][Full Text] [Related]
13. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.
Bowden SJ; Kalliala I; Veroniki AA; Arbyn M; Mitra A; Lathouras K; Mirabello L; Chadeau-Hyam M; Paraskevaidis E; Flanagan JM; Kyrgiou M
EBioMedicine; 2019 Dec; 50():246-259. PubMed ID: 31732479
[TBL] [Abstract][Full Text] [Related]
14. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
[TBL] [Abstract][Full Text] [Related]
15. Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
Park JS; Shin S; Kim EC; Kim JE; Kim YB; Oh S; Roh EY; Yoon JH
APMIS; 2016 Nov; 124(11):950-957. PubMed ID: 27546189
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?
Turan T; Kalantari M; Calleja-Macias IE; Cubie HA; Cuschieri K; Villa LL; Skomedal H; Barrera-Saldaña HA; Bernard HU
Virology; 2006 May; 349(1):175-83. PubMed ID: 16472835
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the methylation of L1 3' and long control region gene of HPV16 DNA and it's pathogenicity].
Hu YJ; Qu PP
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):607-10. PubMed ID: 24199927
[TBL] [Abstract][Full Text] [Related]
20. High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Li X
Clin Biochem; 2015 Sep; 48(13-14):855-9. PubMed ID: 25982893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
